Monday, October 28, 2013

Session Spotlight: The Future of Drug Delivery Technologies: Seeding Ideas in the Market Place

In general, technologies are based on a proprietary idea/technology; their relevant knowledge of the industry segment; and their ability to combine the relevant pieces together, including funding. Drug developers look for technologies that solve problems in their portfolio but there is inefficiency created due to misalignment of what the sellers think the buyers want. How can this misalignment be straightened? 

Session: Future of Drug Delivery Technologies: Seeding Ideas in the Market Place

Speaker: Fernando Sall├ęs, PhD, CLP, Executive Director, Strategic Licensing & Acquisitions Lead, Ophthalmics and Drug Delivery Technologies, Worldwide Licensing & Acquisitions, Merck Research Laboratories

Panelists:
Allen G. Downs, CLP Senior Executive Director, Licensing and Business Development, Purdue Pharma
Riccardo Panicucci, Global Head of Chemical & Pharmaceutical Profiling (CPP), Novartis Institutes For Biomedical Research, Inc.
Herve Abry, European Business Development Manager, BD Medical – Pharmaceutical Systems, Self-Administration Injection Systems

So what is the solution for the great inefficiency in the misalignment of what the sellers think the buyers want? IIR's 18th Annual Drug Delivery Partnerships event will supply you with the solution sets that help you take advantage of trends and jumpstart strategic relationships to leap ahead of the curve. To learn more, download the agenda.

Use priority code XP1978BLOG to register and save $100 off of the current rate. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage. We hope to see you January 27-29 in Boca Raton!

No comments:

Post a Comment